Advertisement
U.S. Markets closed

Cynata Therapeutics Limited (CYP.AX)

ASX - ASX Delayed Price. Currency in AUD
0.2300-0.0100 (-4.17%)
At close: 04:10PM AEDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Expense
16,655
16,543
13,838
9,080
10,512
Operating Income
-16,655
-16,543
-13,838
-9,080
-10,512
Net Non Operating Interest Income Expense
436.244
352.869
64.749
92.299
142.35
Other Income Expense
2,573
1,912
8,328
1,298
6,731
Pretax Income
-13,646
-14,277
-5,445
-7,690
-3,639
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-13,646
-14,277
-5,445
-7,690
-3,639
Basic EPS
-0.10
-0.10
-0.04
-0.06
-0.03
Diluted EPS
-0.10
-0.10
-0.04
-0.06
-0.03
Basic Average Shares
145,092
145,092
143,277
130,427
104,822
Diluted Average Shares
145,092
145,092
143,277
130,427
104,822
Net Income from Continuing & Discontinued Operation
-13,646
-14,277
-5,445
-7,690
-3,639
Normalized Income
-13,646
-14,277
-5,445
-7,690
-3,639
Interest Income
436.244
352.869
64.749
92.299
142.35
Net Interest Income
436.244
352.869
64.749
92.299
142.35
EBIT
-16,655
-16,543
-13,838
-9,080
-10,512
EBITDA
-16,375
-16,263
-13,558
-8,800
-10,232
Reconciled Depreciation
280.348
279.965
279.965
279.965
280.732
Net Income from Continuing Operation Net Minority Interest
-13,646
-14,277
-5,445
-7,690
-3,639
Normalized EBITDA
-16,375
-16,263
-13,558
-8,800
-10,232
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0